S&P 500
(1.03%) 5 180.74 points
Dow Jones
(0.46%) 38 852 points
Nasdaq
(1.19%) 16 349 points
Oil
(0.74%) $78.69
Gas
(2.61%) $2.20
Gold
(1.05%) $2 332.90
Silver
(3.73%) $27.69
Platinum
(0.17%) $966.90
USD/EUR
(-0.02%) $0.929
USD/NOK
(-0.32%) $10.84
USD/GBP
(-0.11%) $0.796
USD/RUB
(-0.09%) $91.37

实时更新: Thyrocare Technologies [THYROCARE.NS]

交易所: NSE 部门: Healthcare 工业: Diagnostics & Research
最后更新时间6 May 2024 @ 17:59

-1.58% INR 621.10

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others...

Stats
今日成交量 19 747.00
平均成交量 109 146
市值 32.89B
EPS INR0 ( 2024-02-01 )
下一个收益日期 ( INR0 ) 2024-05-21
Last Dividend INR18.00 ( 2023-04-20 )
Next Dividend INR0 ( N/A )
P/E 50.74
ATR14 INR0.758 (0.12%)

音量 相关性

長: -0.07 (neutral)
短: -0.52 (weak negative)
Signal:(42.397) Neutral

Thyrocare Technologies 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Thyrocare Technologies 相关性 - 货币/商品

The country flag 0.61
( weak )
The country flag 0.54
( weak )
The country flag 0.80
( strong )
The country flag 0.61
( weak )
The country flag -0.30
( neutral )
The country flag -0.50
( neutral )

Thyrocare Technologies 财务报表

Annual 2022
营收: INR5.27B
毛利润: INR3.63B (69.01 %)
EPS: INR12.16
FY 2022
营收: INR5.27B
毛利润: INR3.63B (69.01 %)
EPS: INR12.16
FY 2022
营收: INR5.89B
毛利润: INR4.19B (71.18 %)
EPS: INR33.30
FY 2021
营收: INR4.95B
毛利润: INR3.31B (66.86 %)
EPS: INR21.41

Financial Reports:

No articles found.

Thyrocare Technologies Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR18.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Thyrocare Technologies Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.68 - low (50.00%) | Divividend Growth Potential Score: 5.11 - Potential for dividend initiation, but uncertain (2.17%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.50 2016-09-01
Last Dividend INR18.00 2023-04-20
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 11 --
Total Paid Out INR105.50 --
Avg. Dividend % Per Year 1.39% --
Score 2.34 --
Div. Sustainability Score 2.68
Div.Growth Potential Score 5.11
Div. Directional Score 3.90 --
Next Divdend (Est)
(2024-06-24)
INR19.97 Estimate 3.36 %
Dividend Stability
0.27 Very Poor
Dividend Score
2.34
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR10.00 1.55%
2019 INR25.00 4.64%
2020 INR10.00 1.85%
2021 INR15.00 1.60%
2022 INR15.00 1.35%
2023 INR18.00 2.94%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PREMIERPOL.NS Dividend Junior 2023-09-11 Sporadic 9 0.39%
KAMDHENU.NS Dividend Junior 2023-08-14 Sporadic 17 0.32%
EDELWEISS.NS Dividend Junior 2023-09-18 Annually 17 2.38%
ADSL.NS Dividend Junior 2023-08-10 Sporadic 16 0.91%
STERTOOLS.NS Dividend Junior 2023-09-11 Annually 19 0.38%
NAHARCAP.NS No Dividend Player 2023-09-08 Annually 17 0.70%
HINDWAREAP.NS Dividend Junior 2023-09-20 Annually 5 0.09%
BSE.NS Dividend Junior 2023-08-04 Annually 8 1.22%
REPCOHOME.NS Dividend Junior 2023-09-07 Annually 12 0.69%
KSL.NS Dividend Junior 2023-08-11 Sporadic 15 1.81%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1181.5007.6310.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1281.5009.6910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM24.851.0001.9091.909[3 - 30]
operatingCashFlowPerShareTTM16.822.004.398.79[0 - 30]
freeCashFlowPerShareTTM16.822.001.5903.18[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.7081.0001.5411.541[0.2 - 0.8]
operatingProfitMarginTTM0.1681.0008.638.63[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score2.68

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM50.161.0005.030[1 - 100]
returnOnEquityTTM0.1282.509.8010.00[0.1 - 1.5]
freeCashFlowPerShareTTM16.822.004.393.18[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM16.822.004.398.79[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.9031.5007.310[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1611.0008.480[0.1 - 0.5]
Total Score5.11

Thyrocare Technologies

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。